- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07672327
Efficacy of Short Wave and Laser Therapy in Patients With Plantar Fasciitis (Blind assessor)
Efficacy of Extracorporeal Shock Wave Therapy Versus High-intensity Laser Therapy in Patients With Plantar Fasciitis
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Mecca Region
-
Mecca, Mecca Region, Saudi-Arabia, 24211
- Mecca
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
1. Patients will be included according to the diagnostic criteria for plantar fasciitis of the American physical therapy association (APTA) (Martin et al., 2014). This criterion includes pain in medial sole and heel of foot: most pronounced in initial steps after a period of inactivity, it also worsens after prolonged weight bearing, pain during palpation and compression of proximal plantar fascia, limited range of motion in active and passive ankle dorsiflexion, positive windlass test.
2. Patients will be referred from an orthopedic surgeon with confirmed diagnosis of plantar fasciitis (Bidoki et al., 2024).
3. Patients with chronic plantar fasciitis (Duration of patient's symptoms will be more than three months) (Riaz et al., 2023).
4. Patients' age will range from 18 to 45 years (Bidoki et al., 2024). 5. Both genders (Riaz et al., 2023). 6. Localized non radiating foot pain with an NPRS more than 5 on the first step in the morning (Riaz et al., 2023).
Exclusion Criteria:
Patients will be excluded if they present any of the following criteria
- History of previous surgery of plantar fasciitis (Riaz et al., 2023).
- History of previous corticosteroid injections (Bidoki et al., 2024).
- History of heel pain due to previous trauma or calcaneus stress fracture in the last 3 months (Bidoki et al., 2024).
- History of previous lumbar spine surgery (Bidoki et al., 2024).
- History of rheumatologic disease (rheumatoid arthritis, diffuse idiopathic skeletal hyperostosis, systemic lupus erythematosus, gout, Sjogren disease, enthesopathy, etc…) (Bidoki et al., 2024).
- Pregnancy, pacemaker fitted or bleeding disorders (Bidoki et al., 2024).
- Wounds, infections or tumors in the treatment area (Bidoki et al., 2024).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Control group
Group (A)
|
exercise
|
|
Eksperimentell: Extracorporeal shock wave therapy
Group (B)
|
ESWT
|
|
Eksperimentell: High-intensity laser therapy
Group (C)
|
HILT
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Hand held dynamometer
Tidsramme: 6 weeks
|
Hand held dynamometer is a portable device, characterized as a low-cost and convenience to assess muscle strength in a clinical setting
|
6 weeks
|
|
Ultrasonography
Tidsramme: 6 weeks
|
Ultrasonography is a type of medical imaging device that uses high-frequency sound (ultrasound) waves to produce images of internal organs and other tissues such as tendons, muscles, joints, blood vessels, and internal organs, to measure some characteristics
|
6 weeks
|
|
Arabic version of foot function index (FFI-Ar)
Tidsramme: 6 weeks
|
Foot functional index is a self-administered index consisting of 23 items divided into 3 subcategories on the basis of: pain, disability and activity limitation.
|
6 weeks
|
|
Arabic version of numerical pain rating scale (NPRS-Ar)
Tidsramme: 6 weeks
|
The Numerical Rating Scale is an 11-point (0-10) Scale that measures pain intensity, it is considered a very sensitive pain assessment scale.
|
6 weeks
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P.T.REC/012/006509
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .